Single‐cell profiling reveals the metastasis‐associated immune signature of hepatocellular carcinoma
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.1264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Deyuan Zhong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Liver Transplantation Center and HBP Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Single-Cell Analysis, Tumor Microenvironment. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Excellent Youth Fund of Sichuan Cancer Hospital, Sichuan Provincial Science and Technology Plan Project.
Abstract (Originalsprache)
Aim
Metastasis is the leading cause of mortality in hepatocellular carcinoma (HCC). The metastasis‐associated immune signature in HCC is worth exploring.
Methods
Bioinformatic analysis was conducted based on the single‐cell transcriptome data derived from HCC patients in different stages. Cellular composition, pseudotime state transition, and cell–cell interaction were further analyzed and verified.
Results
Generally, HCC with metastasis exhibited suppressive immune microenvironment, while HCC without metastasis exhibited active immune microenvironment. Concretely, effector regulatory T cells (eTregs) were found to be enriched in HCC with metastasis. PHLDA1 was identified as one of exhaustion‐specific genes and verified to be associated with worse prognosis in HCC patients. Moreover, A novel cluster of CCR7 + dendritic cells (DCs) was identified with high expression of maturation and migration marker genes. Pseudotime analysis showed that inhibition of differentiation occurred in CCR7 + DCs rather than cDC1 in HCC with metastasis. Furthermore, interaction analysis showed that the reduction of CCR7 + DCs lead to impaired CCR7/CCL19 interaction in HCC with metastasis.
Conclusions
HCC with metastasis exhibited upregulation of exhaustion‐specific genes of eTregs and inhibition of CCL signal of a novel DC cluster, which added new dimensions to the immune landscape and provided new immune therapeutic targets in advanced HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liver Transplantation Center and HBP Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and T…
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau SAR, China.
- Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
ORCID-Profile: Jin Shang
Förderung
- The Excellent Youth Fund of Sichuan Cancer Hospital
- Sichuan Provincial Science and Technology Plan Project
Zitieren
APA
Zhong, D., Shi, Y., Ma, W., Liang, Y., Liu, H., Qin, Y., Zhang, L., Yang, Q., Huang, X., Lu, Y., & Shang, J. (2024). Single‐cell profiling reveals the metastasis‐associated immune signature of hepatocellular carcinoma. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1264
Vancouver
Zhong D, Shi Y, Ma W, Liang Y, Liu H, Qin Y, et al. Single‐cell profiling reveals the metastasis‐associated immune signature of hepatocellular carcinoma. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1264
BibTeX
@article{Zhong2024,
author = {Zhong, Deyuan and Shi, Ying and Ma, Wenzhe and Liang, Yuxin and Liu, Hanjie and Qin, Yingying and Zhang, Lu and Yang, Qinyan and Huang, Xiaolun and Lu, Yuanjun and Shang, Jin},
title = {Single‐cell profiling reveals the metastasis‐associated immune signature of hepatocellular carcinoma},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.1264}
}
EUVIMED